Comparison of pancreatic enzyme abnormalities and protease‐activated receptor‐2‐positive eosinophils in the duodenum of patients with functional dyspepsia‐irritable bowel syndrome overlap with functional dyspepsia alone in Asian populations

BACKGROUND AND AIM Some patients with functional gastrointestinal disorders exhibit pancreatic dysfunctions and pancreatic enzyme abnormalities. Thus, we aimed to clarify whether significant differences in clinical characteristics, prevalence of pancreatic enzyme abnormalities, duodenal inflammation, and protease-activated receptor 2 (PAR2) expression levels related to hypersensitivity exist between functional dyspepsia (FD) alone and FD-irritable bowel syndrome (IBS) overlap group. METHODS Ninety-three patients based on the Rome IV criteria, FD alone (n = 44) and FD overlapped with IBS (n = 49) group were enrolled. The patients scored their own clinical symptoms after consuming high-fat meals. Serum trypsin, PLA2, lipase, p-amylase, and elastase-1 levels were measured. PAR2, eotaxin-3, and TRPV4 mRNA levels in duodenum were determined using real-time polymerase chain reaction methods. PRG2- and PAR2 in the duodenum were evaluated using immunostaining. RESULTS FD score and global GSRS in patients with FD-IBS overlap were significantly higher than FD alone. Although the prevalence of pancreatic enzyme abnormalities in patients with FD alone was significantly (P < 0.01) higher than that in FD-IBS overlap, the ratio of aggravation of clinical symptoms following high-fat intake in patients with FD-IBS overlap was significantly higher (P = 0.007) than that in patients with FD alone. PAR2- and PRG2-double positive cells were localized in the degranulated eosinophils in the duodenum of patients with FD-IBS overlap. The number of PAR2- and PRG2-double positive cells in FD-IBS overlap was significantly (P < 0.01) higher than FD alone. CONCLUSIONS Pancreatic enzyme abnormalities and PAR2 expression on degranulated eosinophils infiltrations in the duodenum may be associated with the pathophysiology of patients with FD-IBS overlap in Asian populations.

[1]  K. Sugano,et al.  Asia‐Pacific guidelines for managing functional dyspepsia overlapping with other gastrointestinal symptoms , 2022, Journal of gastroenterology and hepatology.

[2]  K. Iwakiri,et al.  Trypsin may be associated with duodenal eosinophils through the expression of PAR2 in early chronic pancreatitis and functional dyspepsia with pancreatic enzyme abnormalities , 2022, PloS one.

[3]  G. Docena,et al.  Type-2 Cytokines Promote the Secretion of the Eosinophil–Attractant CCL26 by Intestinal Epithelial Cells in Food-Sensitized Patients , 2022, Frontiers in Immunology.

[4]  Juan A. Sorda,et al.  Exocrine Pancreatic Insufficiency is Undiagnosed in Some Patients with Diarrhea-Predominant Irritable Bowel Syndrome Using the Rome IV Criteria , 2022, Digestive Diseases and Sciences.

[5]  Takatsugu Yamamoto,et al.  Comparison of clinical characteristics, eating behaviors, and clinical symptoms following fat intake in functional dyspepsia with functional dyspepsia with pancreatic enzyme abnormalities between Singapore and Japan , 2022, Journal of gastroenterology and hepatology.

[6]  G. Krasnov,et al.  Disruption of the pro-inflammatory, anti-inflammatory cytokines and tight junction proteins expression, associated with changes of the composition of the gut microbiota in patients with irritable bowel syndrome , 2021, PloS one.

[7]  Y. Kim,et al.  High-Fat Foods and FODMAPs Containing Gluten Foods Primarily Contribute to Symptoms of Irritable Bowel Syndrome in Korean Adults , 2021, Nutrients.

[8]  T. Akamizu,et al.  Comparison of clinical symptoms, gastric motility and fat intake in the early chronic pancreatitis patients with anti-acid therapy-resistant functional dyspepsia patients , 2018, PloS one.

[9]  N. Talley,et al.  Overlap of Irritable Bowel Syndrome and Functional Dyspepsia in the Clinical Setting: Prevalence and Risk Factors , 2018, Digestive Diseases and Sciences.

[10]  P. Bampton,et al.  Undiagnosed pancreatic exocrine insufficiency and chronic pancreatitis in functional GI disorder patients with diarrhea or abdominal pain , 2017, Journal of gastroenterology and hepatology.

[11]  N. Ishimura,et al.  Serum Biomarkers for the Diagnosis of Eosinophilic Esophagitis and Eosinophilic Gastroenteritis , 2017, Internal medicine.

[12]  Nayoung Kim,et al.  Overlap between irritable bowel syndrome and functional dyspepsia including subtype analyses , 2017, Journal of gastroenterology and hepatology.

[13]  T. Akamizu,et al.  Epigastric pain syndrome accompanying pancreatic enzyme abnormalities was overlapped with early chronic pancreatitis using endosonography , 2017, Journal of clinical biochemistry and nutrition.

[14]  Yunxian Yu,et al.  Increased Duodenal Eosinophil Degranulation in Patients with Functional Dyspepsia: A Prospective Study , 2016, Scientific Reports.

[15]  M. Lomer,et al.  British Dietetic Association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults (2016 update). , 2016, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.

[16]  D. Drossman,et al.  Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction. , 2016, Gastroenterology.

[17]  He-sheng Luo,et al.  Tryptase and Protease-Activated Receptor 2 Expression Levels in Irritable Bowel Syndrome , 2015, Gut and liver.

[18]  S. Vanner,et al.  Sensitization of Peripheral Sensory Nerves by Mediators From Colonic Biopsies of Diarrhea-Predominant Irritable Bowel Syndrome Patients: A Role for PAR2 , 2013, The American Journal of Gastroenterology.

[19]  L. Böhn,et al.  Self-Reported Food-Related Gastrointestinal Symptoms in IBS Are Common and Associated With More Severe Symptoms and Reduced Quality of Life , 2013, The American Journal of Gastroenterology.

[20]  F. Azpiroz,et al.  Dietary Lipids and Functional Gastrointestinal Disorders , 2013, The American Journal of Gastroenterology.

[21]  H. Friess,et al.  Neural plasticity in the gastrointestinal tract: chronic inflammation, neurotrophic signals, and hypersensitivity , 2013, Acta Neuropathologica.

[22]  Young Ju Cho,et al.  Stress-induced Alterations in Mast Cell Numbers and Proteinase-activated Receptor-2 Expression of the Colon: Role of Corticotrophin-releasing Factor , 2010, Journal of Korean medical science.

[23]  K. Iwakiri,et al.  Migration of Eosinophils and CCR2-/CD68-Double Positive Cells Into the Duodenal Mucosa of Patients With Postinfectious Functional Dyspepsia , 2010, The American Journal of Gastroenterology.

[24]  R. Sidhu,et al.  Some patients with irritable bowel syndrome may have exocrine pancreatic insufficiency. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[25]  Y. Cho,et al.  Subjects with Diarrhea-Predominant IBS Have Increased Rectal Permeability Responsive to Tryptase , 2010, Digestive Diseases and Sciences.

[26]  A. Zinsmeister,et al.  Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia , 2009, Alimentary pharmacology & therapeutics.

[27]  D. Drossman,et al.  What Patients Know About Irritable Bowel Syndrome (IBS) and What They Would Like to Know. National Survey on Patient Educational Needs in IBS and Development and Validation of the Patient Educational Needs Questionnaire (PEQ) , 2007, The American Journal of Gastroenterology.

[28]  W. van Mechelen,et al.  The effects of a controlled worksite environmental intervention on determinants of dietary behavior and self-reported fruit, vegetable and fat intake , 2006, BMC public health.

[29]  P. Toskes,et al.  Diagnosis and management of chronic pancreatitis , 2005, Postgraduate Medical Journal.

[30]  D. Duerksen,et al.  Intestinal Permeability in Long-Term Follow-up of Patients with Celiac Disease on a Gluten-Free Diet , 2005, Digestive Diseases and Sciences.

[31]  J. Tack,et al.  Impact of Coexisting Irritable Bowel Syndrome on Symptoms and Pathophysiological Mechanisms in Functional Dyspepsia , 2004, American Journal of Gastroenterology.

[32]  M. Crowell,et al.  Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea , 2003, American Journal of Gastroenterology.

[33]  B. Guiard,et al.  Proteinases and proteinase-activated receptor 2: a possible role to promote visceral hyperalgesia in rats. , 2002, Gastroenterology.

[34]  J. Tack,et al.  Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. , 2001, Gastroenterology.

[35]  Ulf Bengtsson,et al.  Food-Related Gastrointestinal Symptoms in the Irritable Bowel Syndrome , 2001, Digestion.

[36]  M. Wallace,et al.  EUS to detect evidence of pancreatic disease in patients with persistent or nonspecific dyspepsia. , 2000, Gastrointestinal endoscopy.

[37]  J. Wallace,et al.  Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism , 2000, Nature Medicine.

[38]  B. Naliboff,et al.  Symptom differences in moderate to severe IBS patients based on predominant bowel habit , 1999, American Journal of Gastroenterology.

[39]  G. Barbara,et al.  Predominant symptoms identify different subgroups in functional dyspepsia , 1999, American Journal of Gastroenterology.

[40]  O. Nyrén,et al.  Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. , 1995, Gastroenterology.